Skip to main content

Advertisement

Log in

Multimodality pictorial review of IgG4-related disease in the abdomen and pelvis

  • Review
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Background

Immunoglobulin G4-related disease (IgG4-RD) is a systemic, immune-mediated disease that can affect multiple organs, including the orbits, salivary glands, thyroid gland, lungs, aorta, pancreas, bile ducts, lymph nodes, and retroperitoneum. While timely diagnosis is particularly important given the efficacy of glucocorticoid treatment for IgG4-RD, accurate recognition can prove a challenge given the overlap between the imaging features of this disease and other entities.

Purpose

After a review of the epidemiology, pathophysiology, and clinical considerations (including treatment) associated with IgG4-RD, this pictorial review will showcase the variable imaging manifestations of this disease in the abdomen and pelvis. Post-treatment imaging appearance of these entities will be reviewed and mimickers of this disease in the abdomen and pelvis will be presented.

Conclusion

The presence of mass-like soft tissue with radiographic characteristics of fibrosis affecting multiple organs should raise suspicion for IgG4-RD, although definite diagnosis can only be made with appropriate clinical, serological, and pathologic data.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13

Similar content being viewed by others

References

  1. Kamisawa, T., et al., IgG4-related disease. The Lancet, 2015. 385(9976): p. 1460-1471.

    Article  CAS  Google Scholar 

  2. Smyrk, T.C., Pathological features of IgG4-related sclerosing disease. Current opinion in rheumatology, 2011. 23(1): p. 74-79.

    Article  CAS  PubMed  Google Scholar 

  3. Carruthers, M.N., et al., The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Annals of the rheumatic diseases, 2015. 74(1): p. 14-18.

    Article  CAS  PubMed  Google Scholar 

  4. Umehara, H., et al., A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Modern rheumatology, 2012. 22(1): p. 1-14.

    Article  CAS  PubMed  Google Scholar 

  5. Wang, L., et al., Sex disparities in clinical characteristics and prognosis of immunoglobulin G4–related disease: a prospective study of 403 patients. Rheumatology, 2019. 58(5): p. 820-830.

    Article  CAS  PubMed  Google Scholar 

  6. Wallwork, R., et al., The association of smoking with immunoglobulin G4–related disease: a case–control study. Rheumatology, 2021. 60(11): p. 5310-5317.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Smerla, R.G., D. Rontogianni, and G.E. Fragoulis, Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report. Clinical Rheumatology, 2018. 37: p. 1721-1727.

  8. Chen, Y., et al., Aberrant expansion and function of follicular helper T cell subsets in IgG4‐related disease. Arthritis & Rheumatology, 2018. 70(11): p. 1853-1865.

    Article  CAS  Google Scholar 

  9. Ito, F., et al., IL-10+ T follicular regulatory cells are associated with the pathogenesis of IgG4-related disease. Immunology Letters, 2019. 207: p. 56-63.

    Article  CAS  PubMed  Google Scholar 

  10. Mattoo, H., et al., Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease. Journal of Allergy and Clinical Immunology, 2016. 138(3): p. 825-838.

    Article  CAS  PubMed  Google Scholar 

  11. Zhang, P., et al., Phenotype, function and clinical significance of innate lymphoid cells in immunoglobulin G4–related disease. Rheumatology, 2022. 61(5): p. 2197-2209.

    Article  CAS  PubMed  Google Scholar 

  12. Mahajan, V.S., et al., IgG4-related disease. Annual Review of Pathology: Mechanisms of Disease, 2014. 9: p. 315-347.

    Article  CAS  Google Scholar 

  13. LIU, L.J., et al., IgG subclass distribution, affinity of anti‐myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis. Nephrology, 2008. 13(7): p. 629-635.

    Article  CAS  PubMed  Google Scholar 

  14. Okazaki, K., et al., Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. Journal of gastroenterology, 2011. 46: p. 277-288.

    Article  CAS  PubMed  Google Scholar 

  15. Sah, R.P., et al., Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology, 2010. 139(1): p. 140-148.

    Article  PubMed  Google Scholar 

  16. Perugino, C.A. and J.H. Stone, IgG4-related disease: an update on pathophysiology and implications for clinical care. Nature Reviews Rheumatology, 2020. 16(12): p. 702-714.

    Article  CAS  PubMed  Google Scholar 

  17. Hamano, H., et al., Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. Journal of gastroenterology, 2006. 41: p. 1197-1205.

    Article  PubMed  Google Scholar 

  18. Wallace, Z.S., et al., IgG4‐related disease: clinical and laboratory features in one hundred twenty‐five patients. Arthritis & rheumatology, 2015. 67(9): p. 2466-2475.

    Article  CAS  Google Scholar 

  19. Lanzillotta, M., G. Mancuso, and E. Della-Torre, Advances in the diagnosis and management of IgG4 related disease. Bmj, 2020. 369.

  20. Fritz, S., Diagnosis and treatment of autoimmune pancreatitis types 1 and 2. British journal of surgery. 101(10): p. 1257-1265.

  21. Hart, P.A., Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience. Gut. 65(10): p. 1702-1709.

  22. Hart, P.A., Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 62(12): p. 1771-1776.

  23. Zhang, L., et al., Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas, 2011. 40(8): p. 1172-1179.

    Article  CAS  PubMed  Google Scholar 

  24. Masamune, A., Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. Journal of gastroenterology. 55(4): p. 462-470.

  25. Sahani, D.V., et al., Autoimmune pancreatitis: imaging features. Radiology, 2004. 233(2): p. 345-352.

    Article  PubMed  Google Scholar 

  26. Yang, D., et al., Autoimmune pancreatitis: radiologic findings in 20 patients. Abdominal imaging, 2006. 31: p. 94-102.

    Article  CAS  PubMed  Google Scholar 

  27. Vlachou, P.A., et al., IgG4-related Sclerosing Disease: Autoimmune Pancreatitis and Extrapancreatic Manifestations. Radiographics. 31(5): p. 1379-1402.

  28. Carbognin, G., et al., Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP. La radiologia medica, 2009. 114(8): p. 1214-1231.

    Article  CAS  PubMed  Google Scholar 

  29. Suzuki, K., et al., CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT. Clinical radiology, 2010. 65(9): p. 735-743.

    Article  CAS  PubMed  Google Scholar 

  30. Takahashi, M., Diagnostic imaging guide for autoimmune pancreatitis. Japanese journal of radiology. 38(7): p. 591-612.

  31. Tang, C.S.W., N. Sivarasan, and N. Griffin, Abdominal manifestations of IgG4-related disease: a pictorial review. Insights into imaging, 2018. 9: p. 437-448.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kim, H.J., et al., Pancreatic duct “Icicle sign” on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas. European radiology, 2015. 25: p. 1551-1560.

    Article  PubMed  Google Scholar 

  33. Martínez-de-Alegría, A., et al., IgG4-related disease from head to toe. Radiographics, 2015. 35(7): p. 2007-2025.

    Article  PubMed  Google Scholar 

  34. Ichikawa, T., et al., Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology, 2001. 221(1): p. 107-116.

    Article  CAS  PubMed  Google Scholar 

  35. Hirano, K., et al., Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointestinal endoscopy, 2010. 71(1): p. 85-90.

    Article  PubMed  Google Scholar 

  36. Kawai, Y., et al., Autoimmune pancreatitis: assessment of the enhanced duct sign on multiphase contrast-enhanced computed tomography. European journal of radiology, 2012. 81(11): p. 3055-3060.

    Article  PubMed  Google Scholar 

  37. Hedgire, S.S., et al., The spectrum of IgG4-related disease in the abdomen and pelvis. American Journal of Roentgenology, 2013. 201(1): p. 14-22.

    Article  PubMed  Google Scholar 

  38. Muhi, A., et al., Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. Journal of magnetic resonance imaging. 35(4).

  39. Hafezi-Nejad, N., et al., MR Imaging of Autoimmune Pancreatitis. Magnetic Resonance Imaging Clinics of North America, 2018. 26(3): p. 463-478.

    Article  PubMed  Google Scholar 

  40. Huggett, M.T., et al., Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. The American journal of gastroenterology, 2014. 109(10): p. 1675.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Culver, E.L. and G. Webster, IgG4-related sclerosing cholangitis. Biliary Disease: From Science to Clinic, 2017: p. 243-261.

  42. Khosroshahi, A., A clinical overview of IgG4-related systemic disease. Current opinion in rheumatology. 23(1): p. 57-66.

  43. Ghazale, A., Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (New York, N.Y. 1943). 134(3): p. 706-715.

  44. Zheng, Y., et al., IgG4-related disease in the abdomen and pelvis: atypical findings, pitfalls, and mimics. Abdominal Radiology, 2020. 45: p. 2485-2499.

    Article  PubMed  Google Scholar 

  45. Tan, T.J., et al., Extrapancreatic findings of IgG4-related disease. Clinical radiology, 2014. 69(2): p. 209-218.

    Article  CAS  PubMed  Google Scholar 

  46. Horger, M., et al., Systemic IgG4-related sclerosing disease: spectrum of imaging findings and differential diagnosis. American Journal of Roentgenology, 2012. 199(3): p. W276-W282.

    Article  PubMed  Google Scholar 

  47. Madhusudhan, K.S., et al., IgG4-related sclerosing cholangitis: a clinical and imaging review. American Journal of Roentgenology, 2019. 213(6): p. 1221-1231.

    Article  PubMed  Google Scholar 

  48. Fujinaga, Y., et al., Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. European journal of radiology, 2010. 76(2): p. 228-238.

    Article  PubMed  Google Scholar 

  49. Nikiphorou, E., Overview of IgG4-related aortitis and periaortitis. A decade since their first description. Autoimmunity reviews. 19(12).

  50. Neild, G.H., Hyper-IgG4 disease: report and characterisation of a new disease. BMC medicine. 4(1).

  51. Zen, Y., Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. The American journal of surgical pathology. 33(12): p. 1833-1839.

  52. Hamano, H., Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 359(9315): p. 1403-1404.

  53. Stone, J.R., Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Current opinion in rheumatology. 23(1): p. 88-94.

  54. Khosroshahi, A., Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore). 92(2): p. 82-91.

  55. Kim, J.H., et al., Atypical manifestations of IgG4-related sclerosing disease in the abdomen: imaging findings and pathologic correlations. American Journal of Roentgenology, 2013. 200(1): p. 102-112.

    Article  PubMed  Google Scholar 

  56. Cohan, R.H., et al., Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made? Abdominal Radiology, 2018. 43: p. 1204-1214.

    Article  PubMed  Google Scholar 

  57. Perugino, C.A., Large vessel involvement by IgG4-related disease. Medicine (Baltimore). 95(28).

  58. Peng, L., IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease. Arthritis research & therapy. 22(1).

  59. Ozawa, M., et al., Clinical features of IgG4-related periaortitis/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case–control study. Arthritis research & therapy, 2017. 19: p. 1-9.

    Article  Google Scholar 

  60. Fragoulis, G.E., Vasculitis beyond aortitis in IgG4-related disease (IgG4-RD): case report and review of the literature. Clinical rheumatology. 40(3): p. 1167-1173.

  61. Inoue, D., IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 94(15).

  62. Inoue, D., Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology. 261(2): p. 625-633.

  63. Oyama-Manabe, N., et al., RadioGraphics Update: IgG4-related Cardiovascular Disease from the Aorta to the Coronary Arteries. RadioGraphics, 2020. 40(7): p. E29-E32.

    Article  PubMed  Google Scholar 

  64. Lanzafame, L.R., et al., Multimodality Imaging Evaluation of Coronary IgG4-Related Disease: A “Tumor-Like” Cardiac Lesion. Diagnostics, 2022. 12(11): p. 2814.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Mizushima, I., et al., Clinical course after corticosteroid therapy in IgG4-related aortitis/periaortitis and periarteritis: a retrospective multicenter study. Arthritis research & therapy, 2014. 16(4): p. 1-11.

    Article  CAS  Google Scholar 

  66. Cheuk, W., et al., Lymphadenopathy of IgG4-related sclerosing disease. The American journal of surgical pathology, 2008. 32(5): p. 671-681.

    Article  PubMed  Google Scholar 

  67. Zen, Y. and Y. Nakanuma, IgG4-related disease: a cross-sectional study of 114 cases. The American journal of surgical pathology, 2010. 34(12): p. 1812-1819.

    Article  PubMed  Google Scholar 

  68. Saegusa, H., et al., Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas, 2003. 27(1): p. 20-25.

    Article  PubMed  Google Scholar 

  69. Bookhout, C.E. and M.A. Rollins-Raval, Immunoglobulin G4–Related Lymphadenopathy. Surgical Pathology Clinics, 2016. 9(1): p. 117-129.

    Article  PubMed  Google Scholar 

  70. Saeki, T., et al., Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney international, 2010. 78(10): p. 1016-1023.

    Article  CAS  PubMed  Google Scholar 

  71. Ling, J., et al., Clinical and imaging features of IgG4-related kidney disease. Abdominal Radiology, 2020. 45: p. 1915-1921.

    Article  PubMed  Google Scholar 

  72. Kim, B., et al., IgG4-related kidney disease: MRI findings with emphasis on the usefulness of diffusion-weighted imaging. European journal of radiology, 2014. 83(7): p. 1057-1062.

    Article  PubMed  Google Scholar 

  73. Yoshimura, Y., et al., IgG4-associated prostatitis complicating autoimmune pancreatitis. Internal Medicine, 2006. 45(15): p. 897-901.

    Article  PubMed  Google Scholar 

  74. Liu, H., et al. Prostate and pancreas involvement are linked in IgG4-related disease. in Seminars in Arthritis and Rheumatism. 2020. Elsevier.

  75. Buijs, J., et al., Immunoglobulin G4-related prostatitis: a case-control study focusing on clinical and pathologic characteristics. Urology (Ridgewood, N.J.). 83(3): p. 521-526.

  76. Jazdarehee, A., et al., IgG4-related prostatitis manifesting as urinary obstruction in a 28-year-old male. BMC urology, 2022. 22(1): p. 35.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Bourlon, M.T., et al., IgG4-related autoimmune prostatitis: is it an unusual or underdiagnosed manifestation of IgG4-related disease? Case reports in urology, 2013. 2013.

  78. Nishimori, I., et al., IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Internal Medicine, 2007. 46(24): p. 1983-1990.

    Article  PubMed  Google Scholar 

  79. Vadi, S.K., et al., IgG4-related disease simulating carcinoma colon with diffuse peritoneal carcinomatosis on 18F-FDG PET/CT. Clinical nuclear medicine, 2018. 43(7): p. e247-e249.

    Article  PubMed  Google Scholar 

  80. Coulier, B., et al., Small bowel obstruction caused by peritoneal immunoglobulin g4-related disease mimicking carcinomatosis: case report. Korean Journal of Radiology, 2014. 15(1): p. 66-71.

    Article  PubMed  PubMed Central  Google Scholar 

  81. González-Moreno, J., et al., Serosal involvement in IgG4-related disease: report of two cases and review of the literature. Rheumatology international, 2016. 36: p. 1033-1041.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suzanne Czerniak.

Ethics declarations

Conflict of interest

Suzanne Czerniak, Aditya Rao, and Mahan Mathur declares that they have no conflicts of interest

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Czerniak, S., Rao, A. & Mathur, M. Multimodality pictorial review of IgG4-related disease in the abdomen and pelvis. Abdom Radiol 48, 3147–3161 (2023). https://doi.org/10.1007/s00261-023-03996-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-023-03996-w

Keywords

Navigation